<DOC>
	<DOCNO>NCT00396916</DOCNO>
	<brief_summary>The purpose present study assess role hybrid PET/CT image diagnosis active malignancy cancer patient rise tumor marker treatment diagnosis primary tumor patient metastatic cancer unknown origin . The clinical impact PET/CT management treatment two group cancer patient evaluate</brief_summary>
	<brief_title>Hybrid PET/CT Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Cancer patient complete remission treatment , serial elevation serum tumor marker negative CT conventional imaging test . Patients newly diagnose metastatic cancer unknown primary tumor Glucose level 150200 Patient sign informed consent Pregnant lactate woman Patient unable willing tolerate test completion One inclusion criterion fulfil</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>cancer patient</keyword>
</DOC>